chr3-49012203-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018031.6(WDR6):āc.669G>Cā(p.Leu223Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000743 in 1,614,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018031.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR6 | NM_018031.6 | c.669G>C | p.Leu223Phe | missense_variant | 2/6 | ENST00000608424.6 | NP_060501.4 | |
WDR6 | NM_001320546.3 | c.591G>C | p.Leu197Phe | missense_variant | 2/6 | NP_001307475.1 | ||
WDR6 | NM_001320547.2 | c.516G>C | p.Leu172Phe | missense_variant | 2/6 | NP_001307476.1 | ||
WDR6 | XM_047447371.1 | c.669G>C | p.Leu223Phe | missense_variant | 2/5 | XP_047303327.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251458Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135900
GnomAD4 exome AF: 0.0000787 AC: 115AN: 1461892Hom.: 0 Cov.: 34 AF XY: 0.0000770 AC XY: 56AN XY: 727246
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152376Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2023 | The c.759G>C (p.L253F) alteration is located in exon 2 (coding exon 2) of the WDR6 gene. This alteration results from a G to C substitution at nucleotide position 759, causing the leucine (L) at amino acid position 253 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at